The Series B round was led by Bertelsmann India Investments, with continued support from existing investors Elevar Equity and British International Investment.
The journey from being a successful local player to a thriving global entity involves various challenges, including market entry strategies, cultural adaptation, and regulatory hurdles.
Scimplify will use the funding to expand beyond 16 countries and strengthen its presence in life sciences, crop sciences, and industrial chemicals, tackling sourcing, regulatory, and large-scale manufacturing challenges.
The Bengaluru-based platform aims to deploy the fresh funds to accelerate product expansion, bolster team growth, and foster innovation in diagnostics.
The Bengaluru-based platform aims to deploy the raised funds to double down on its R&D capabilities and add more geographies where key customer segments lie.
The Delhi-based startup will utilise the fresh funds to fuel its expansion into new districts, upgrade its technology platform, and increase hiring in technology, product, and operations teams.
The funds raised will be deployed towards deeper investment in product development as well as technology across systems, user experience and building world-class laboratories